
GNCP does not currently pay a dividend.
See exactly how GNCP's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GNCP and 80,000+ other tickers.
GNCC Capital, Inc., operating through its subsidiary BioCann Pharma S.A.S., specializes in the production and marketing of pharmaceutical-grade CBD oils derived from cannabis. These products are distributed via established networks throughout Colombia and across the broader Latin American market. The parent company's headquarters are located in Las Vegas, Nevada.
No recent news available.